In the media
February 16, 2022
On BBC Radio 5 Live, Owkin co-founder and CEO Thomas Clozel explains our new AI project to better detect HER2-positive breast cancer
Today our co-founder and CEO Thomas Clozel joined Naga Munchetty on B Radio to discuss our new project to develop hashtag#AI models to better detect HER2-positive breast cancer in women.
Share to:
About Owkin
Owkin is an agentic AI company pioneering Biological Artificial Superintelligence to solve problems in biology where human researchers alone have failed.
Owkin builds K Pro - an AI scientist for pharmaceutical research and strategic decision-making. K Pro orchestrates a suite of AI skills and tools to decode complex biology, accelerate research, and dramatically increase productivity.
K Pro is built on Owkin’s unrivalled multimodal patient data network, state-of-the-art AI for biology and a decade of experience working with pharmaceutical partners.
